|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
0.13/0.37
|
企業價值
119.93M
|
資產負債 |
每股賬面淨值
0.54
|
現金流量 |
現金流量率
--
|
損益表 |
收益
79.18M
|
每股收益
4.00
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/09/21 05:44 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others. |